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A B S T R A C T
Background: Age–period–cohort (APC) analysis could provide useful insight into the interpretation of
time trends for disease rates. This study aimed to determine whether the patterns of age, period and
cohort effects on epilepsy mortality in Taiwan were similar to those in the US and in England andWales.
Methods: We employed a three-phase APC analysis method developed by Keyes and Li,7 which
conceptualizes the cohort effect as a partial interaction between age and period. The effects of age,
period, and cohort were indicated by the relative risk (RR) of mortality rates.
Results: We found an increase in mortality rates in the elderly from 1981–85 to 2001–05 and no decline
in mortality rates for children, adolescents and adults from 1991–95 to 2001–05. According to APC
analysis, the RRs increased sharply during adolescence, and leveled off in adulthood, and then increased
steeply in the elderly. The RR of period effects decreased from period 1971–1975 to period 1991–1995
and then increased. With the exception of cohort 1911–1915, no signiﬁcant cohort effects were found.
Conclusion: Despite the limitations of ofﬁcial published mortality data, we still found prominent age
effects according to APC analysis, which were similar to the results of a previous study. However, the
patterns of period and cohort effects in relation to epilepsy mortality in Taiwan differed from those in
England and Wales and in the US.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Age–period–cohort (APC) analysis could provide useful insight
into the interpretation of time trends for disease rates.1,2 The age
effect represents the differing risks associated with different age
groups. The period effect represents a change in rate that is
associated with all age groups simultaneously. The cohort effect is
associated with a change in rates in successive age groups in
successive time periods. The APC model has been used to analyze
the time trends in epilepsy mortality in England and Wales and in
the US between 1950 and 1994, and indicated pronounced cohort
effects.3 In the US, epilepsy mortality fell with each successive
cohort after 1905, while in England andWales, there was a similar
decline in cohort mortality after 1905 for women, but this was not
observed until after 1950 for men.
In addition to the secular trend, there are geographic variations
in epilepsy mortality rates across countries.4 As indicated by a
recent review, the epidemiology of epilepsy in Asian countries is* Corresponding author at: NCKU Research Center for Health Data and Institute of
Public Health, College of Medicine, National Cheng-Kung University, No.1 Dah
Hsueh Road, Tainan 701, Taiwan.
Tel.: +886 6 2353535x5867/5567; fax: +886 6 2359033.
E-mail address: robertlu@mail.ncku.edu.tw (T.-H. Lu).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.12.001underappreciated.5Most of the previous epilepsymortality studies
were performed inWestern countries, and little is knownabout the
experience in Asian countries. We therefore aimed in this study to
use the APC model to examine the epilepsy mortality trends in
Taiwan between 1971 and 2005 and to determine whether the
patterns of age, period and cohort effects on epilepsy mortality in
Taiwan were similar to those in the US and in England and Wales.
2. Materials and methods
2.1. Data sources
Mortality data for the years 1971 through 2005 were retrieved
from Taiwan’s National Mortality Registry, Department of Health.
The population data were derived from the national annual
household registration statistics published by the Ministry of the
Interior of Taiwan. The International Classiﬁcation of Diseases, Eighth
and Ninth Revisions (ICD-8 and ICD-9) code 345was used to identify
deaths in which the underlying-cause-of-death was epilepsy.
2.2. Calculation of mortality rates
Themortality ratewas calculated for ﬁfteen 5-year age intervals
(i.e., 0–4, 5–9, 10–14, . . ., 65–69 and 70–74 years old) and seven 5-
year calendar periods (1971–75, 1976–80, 1981–85,1986–90,vier Ltd. All rights reserved.
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Fig. 1. Secular trend in the age-speciﬁc epilepsy mortality rate in Taiwan, 1971–
2005.
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Fig. 2. Epilepsy mortality by cohort in Taiwan, 1971–2005.
Y.-H. Chang et al. / Seizure 20 (2011) 240–243 2411991–95, 1996–00 and 2001–05). Based on such age and period
classiﬁcations, 21(15 + 7  1 = 21) consecutive 5-year birth
cohorts were identiﬁed (i.e., 1901–05, 1906–10, 1911–15, . . .
2001–05). We re-categorized the 21 birth cohorts into 5 birth
cohorts with a wider birth-year interval, i.e., 1901–20, 1921–40,
1941–60, 1961–80, and 1981–05 to calculate the age- and sex-
speciﬁc mortality rates by birth cohort. We ﬁrst depicted the
secular trend in the mortality rate of epilepsy according to age and
sex between 1971 and 2005 and then calculated the age- and sex-
speciﬁc mortality rates for each birth cohort.
2.3. APC analysis
To solve the limitations of traditional statistical models in
assessing the respective effects of age, period and cohort, we
employed a three-phase method that conceptualizes the cohort
effect as a partial interaction between age and period.6,7 The three-
phase method begins with graphical inspection; second, a median
polish is used to remove the log-additive components of age and
period effects; and third, a linear regression of residuals from the
median polish is modeled to quantify the relativemagnitude of the
cohort effect.7
According to Keyes and Li,7 a general two-factor model for the
rate (Yij) is that it is a function of vector (ai), the ith of m  1 age
effects, and vector (bj), the jth of n  1 period effects. The natural
log of Yij is modeled as a constant term (m) plus ai, bj, and an error
term (eij):
LogðYi jÞ ¼ mþ ai þ b j þ ei j (1)
The error term represents the residual unaccounted for by the
log-additive effects of age and period. Eq. (1) can be rewritten as:
LogðYi jÞ ¼ mþ ai þ b j þ di j (2)
where dij denotes a multiplicative interaction between the age and
period effects. Eq. (2) represents the saturated model of the age-
period data; the error term in the model is equal to zero. The
variance attributable to the multiplicative interaction term in the
fully-saturated model is then partitioned into systematic and non-
systematic components. The systematic component is considered
the cohort effect, and the remaining variance is considered random
error. Thus, the cohort effect is a partial multiplicative interaction
between age and period.
The effect of each parameter (i.e., age, period, and cohort) was
indicated by the relative risk (RR) and 95% conﬁdence intervals
(95% CI), using the age interval of 35–39 years, the 1986–1990
calendar period, and the 1951–1955 cohort as references. The
statistical signiﬁcance of the epilepsy mortality rates by age,
period, and cohort individually or collectively was tested using
analyses of deviance for the regression model. All analyses were
performed using SAS 8.0 (SAS Institute, Cary, NC).8
3. Results
During the study period, a total of 5226 deaths from epilepsy
were identiﬁed from the dataset. Themortality rates were found to
be higher in males than in females; however, the effects of age,
period, and cohort were similar for both sexes, and we therefore
have not presented the results by sex in the following sections. The
secular trend in epilepsy mortality differed by age (Fig. 1). The
mortality rate for the elderly declined ﬁrst from 1971–75 to 1981–
85 and then increased consistently from 1981–85 to 2001–05.
However, the mortality rates for children, adolescents and adults
have not declined since 1991–95. Fig. 2 shows the cohort-speciﬁc
mortality from epilepsy. We found that the later the cohort
(especially 1961–80 and 1981–05), the lower the mortality rate.The mortality rates for children and adolescents in the cohort of
1981–05 were lower than those in the cohort of 1961–80.
The effects of components of the APC model on epilepsy
mortality are shown in Fig. 3 and Table 1. We found profound
effects of age on epilepsy mortality in Taiwan. The RR increased
sharply during adolescence, leveled off during adulthood, and then
increased steeply in the elderly. Using age group 35–39 year old as
a reference, the RR was signiﬁcantly lower than the reference for
deceased aged 0–19 years and signiﬁcantly higher for deceased
aged 65 years and above.
The RR of period effects decreased from period 1971–1975 to
period 1991–1995 and then increased from period 1991–1995 to
period 2001–2005. However, the changes were not statistically
signiﬁcant. We did not ﬁnd any signiﬁcant cohort effects, with the
exception of cohort 1911–1915, which had a signiﬁcantly lower RR
as compared with the reference cohort (i.e., 1951–1955).
4. Discussion
4.1. Main ﬁndings
Some of the ﬁndings (age effects) of APC model analysis in this
study were similar to those of previous research, such as an
increase in mortality risk during adolescence and old age.
However, some of the ﬁndings (period and cohort effects) differ
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Fig. 3. Adjusted epilepsy mortality rate ratios of age, period, and cohort effects
according to age–period–cohort analysis in Taiwan, 1971–2005.
Y.-H. Chang et al. / Seizure 20 (2011) 240–243242from those of previous studies. We found a steeper increasing
mortality trend among the elderly, no decline in the mortality rates
for children, adolescents and adults, and no decrease in mortality
risk in recent successive cohorts in Taiwan; these results were in
contrast with those reported for England andWales and for the US.3Table 1
Rate ratios and 95% conﬁdence intervals (95% CI) of age, period, and cohort effects
according to age–period–cohort (APC) analysis of epilepsy mortality in Taiwan,
1971–2005.
APC analysis Rate ratio 95% CI
Age
0–4 0.70 0.61–0.79
5–9 0.52 0.46–0.59
10–14 0.58 0.51–0.66
15–19 0.69 0.61–0.79
20–24 0.93 0.82–1.06
25–29 0.98 0.86–1.11
30–34 0.93 0.82–1.06
35–39 1.00 Reference
40–44 0.93 0.82–1.06
45–49 0.93 0.82–1.06
50–54 0.90 0.79–1.03
55–59 1.00 0.88–1.14
60–64 0.99 0.87–1.13
65–69 1.19 1.05–1.35
70–74 1.42 1.25–1.61
Period
1971–1975 1.15 0.95–1.39
1976–1980 1.10 0.91–1.34
1981–1985 1.08 0.89–1.30
1986–1990 1.00 Reference
1991–1995 0.82 0.67–0.99
1996–2000 0.90 0.74–1.09
2001–2005 1.02 0.84–1.23
Cohort
1911–1915 0.65 0.48–0.88
1916–1920 0.91 0.70–1.20
1921–1925 1.07 0.83–1.38
1926–1930 0.94 0.74–1.20
1931–1935 1.05 0.84–1.33
1936–1940 1.04 0.83–1.31
1941–1945 0.93 0.73–1.17
1946–1950 1.03 0.82–1.30
1951–1955 1.00 Reference
1956–1960 1.00 0.79–1.26
1961–1965 0.97 0.77–1.22
1966–1970 0.94 0.75–1.19
1971–1975 0.86 0.68–1.09
1976–1980 0.85 0.67–1.08
1981–1985 0.88 0.68–1.13
1986–1990 0.88 0.67–1.15
1991–1995 1.00 0.74–1.344.2. Limitations of this study
Before we move to the interpretation of the ﬁndings of this
study, we should ﬁrst examine the limitations of this study. Several
scholars have pointed out methodological issues in studies of
mortality from epilepsy.9–13 One of the limitations of this study
was the use of ofﬁcial published mortality data instead of cohorts
of patients with epilepsy. The ofﬁcial published mortality data are
based on the underlying cause-of-death, which is deﬁned as the
disease or injury that initiated the train of morbid events.14 Given
the same epilepsy-related death (e.g., drowning while seizing,
aspiration pneumonia during a seizure, etc.), epilepsy might be
reported as the underlying cause-of-death by some certifying
physicians and as a contributory cause-of-death by other certifying
physicians, and we were unable to differentiate whether a death
was directly or indirectly due to epilepsy.
Another limitation in using ofﬁcial published mortality data
was the underreporting of epilepsy on death certiﬁcates. According
to the study of Bell et al., in only 7% of patients with epilepsy is
epilepsy reported on the death certiﬁcate. In some patients with
active epilepsy, epilepsy does not appear on the death certiﬁcate.10
The reporting rate was estimated to be around 10% in Taiwan
according to the study of Tsai.12 Given the above limitations,
caution should be taken in interpreting the epilepsy mortality
trends.
4.3. Interpreting the ﬁndings
O’Callaghan et al.3 suggested that the increase in mortality risk
during adolescence might be due to poor compliance with
antiepileptic treatment, as during this age period adolescents
are moving away from parental supervision. The subsequent
leveling-off in mortality during adulthood may reﬂect a more
responsible approach that comes with increasing maturity.
The increase in mortality risk from epilepsy among the elderly
in Taiwan is compatible with the age pattern of the prevalence of
treated epilepsy estimated according to the National Health
Insurance dataset.15 The prevalence of cerebrovascular disease
increases with age, and it is well-known that cerebrovascular
disease is an important risk factor of symptomatic epilepsy;
therefore, we could expect a higher prevalence of epilepsy among
the elderly, consequently resulting in a higher mortality from
epilepsy.16
Unlike the pattern of mortality trends (i.e., a prominent
decrease for the deceased aged 69 years old and lower and a
mild increase for the elderly aged 70 and above) in England and
Wales and in the US, a steep increase in mortality rates among the
elderly and no decline in mortality rates among children,
adolescents and adults were found in Taiwan. Even worse, we
found an increase in mortality risk in the periods 1996–2000 and
2001–2005 and cohort 1991–1995 according to APC analysis.
One possible explanation of the higher mortality from epilepsy
in Taiwan is the poorer quality of treatment of patients with
epilepsy in Taiwan as compared with England and Wales and the
US. One hospital-based study in Taiwan suggested a higher fatality
rate of patients with epilepsy as compared with similar hospital-
based studies in Japan and India.17 In addition, a nationwide
population-based study indicated that the antiepileptic drugs used
in Taiwan were dominated by ﬁrst-generation drugs and the mean
dosages of most antiepileptic drugs were lower than those
suggested by the World Health Organization.18
However, the above hypothesis does not explain the increase in
mortality risk in the periods 1996–2000 and 2001–2005 and
cohort 1991–1995 according to APC analysis. One possible
explanation is the implementation of the National Health
Insurance (NHI) program in Taiwan in 1993, which removed
Y.-H. Chang et al. / Seizure 20 (2011) 240–243 243ﬁnancial barriers to accessing health care.19 Evaluation studies
have suggested that the NIH program is of most beneﬁt to children,
the elderly, and people living in the most deprived areas.20,21 It is
highly possible that more patients with epilepsy receive regular
treatment owing to the NHI program and therefore a diagnosis of
‘‘epilepsy’’ is more likely to be reported as a COD on the death
certiﬁcate by certifying physicians.
Another possible explanation is the improvement in COD
reporting and the coding procedure since 2000. The Department of
Health of Taiwan initiated a systematic evaluation of the quality of
COD reporting by certifying physicians and the quality of the
coding procedure in selecting the underlying COD in the late
1990s.22,23 The Department of Health then introduce ACME,
software developed by the National Center for Health Statistics of
the US, to standardize the procedure for selecting the underlying
COD in the early 2000s.24,25 The increase in mortality rates might
to some extent reﬂect better reporting and coding of epilepsy-
related deaths rather than a real increase in mortality risk. Further
studies are needed to examine this hypothesis.
In conclusion, despite the limitations of using ofﬁcial published
mortality data, we nevertheless found prominent age effects
according to APC analysis, which were similar to the results of
previous research. However, the patterns of the period and cohort
effects on epilepsy mortality in Taiwan differed from those in
England and Wales and in the US. Further studies are needed to
examine the reasons for the lack of a decline in mortality in period
2001–2005 and the later cohorts in Taiwan.
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